A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

July 31, 2006

Conditions

Type 1 Diabetes

Interventions

DRUG

very low dose (VLD) glucagon

Trial Locations (1)

University Of California, San Diego, San Diego